Compare Packaging Corporation of America (PKG) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Packaging Corporation of America vs Twist Bioscience Corp — how do they compare? Packaging Corporation of America trades at $230.97 (market cap $20.49B), while Twist Bioscience Corp trades at $161.93 (market cap $10.08B). The key difference: Packaging Corporation of America is far larger — about 2× Twist Bioscience Corp's market cap, and Packaging Corporation of America pays a 2.61% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Packaging Corporation of America for 45 Days and Twist Bioscience Corp for 27 Days on average.
| PKG | TWST | |
|---|---|---|
Market Cap | $20.49B | $10.08B |
Volume | 493,499 | 4,229,037 |
Sector | Consumer Cyclical | Health |
52-Week High | $257.43 | $205.00 |
52-Week Low | $191.68 | $25.45 |
Typical Hold Time | 45 Days | 27 Days |
Enterprise Value | $24.30B | $10.01B |
Dividend Yield | 2.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Packaging Corporation of America (PKG) trades at $230.04, up 1.23% on the day, amid a bearish technical signal but with mixed fundamental performance. The stock shows a P/E of 29.86 and net income margin of 7.26%, with Q2 2026 earnings beating estimates. Recent news highlights institutional investments and a scheduled Q3 earnings call, while cash flow trends indicate increased capital expenditures.
PKG presents a cautious outlook with analyst consensus leaning Hold (57.69%) and a price target of $272.43 suggesting upside potential. Key risks include cost pressures and negative net cash flow, but strong corrugated demand and dividend payments offer stability. The stock's performance hinges on Q3 earnings results and margin management amid inflationary headwinds.
Twist Bioscience (TWST) trades at $162.43, up 4.36% today, showing strong momentum despite recent earnings misses. The stock maintains a bullish technical signal with RSI at 29.02 indicating potential oversold conditions. Fundamentally, revenue growth continues (2025: $377M, 2026: $432M projected) but profitability remains elusive with negative margins. Recent partnership with Eli Lilly's TuneLab platform highlights strategic positioning in AI-driven drug discovery.
While analyst consensus favors Buy (73%), the stock trades above the $145.20 target, suggesting limited near-term upside. Key risks include persistent cash burn (-$44M net CF in 2025) and high valuation multiples (P/S: 21.5). The AI biotech partnership provides growth catalyst potential, but profitability timeline remains uncertain for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Packaging Corporation of America
Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
